Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Capitalistaon Nov 19, 2022 3:02pm
298 Views
Post# 35112865

RE:"Griproom" article - 10 signs your company is to be acquired

RE:"Griproom" article - 10 signs your company is to be acquired

This last part describes ONC's trading pattern quite well. In what rational world would an announcement of a dramatically improved cancer treatment have no lasting effect on stock price? Scum and villainy abound. (Cue the dixieland oboe)


10. Your stock has become disconnected from reality

It becomes painfully obvious that your stock is being manipulated if instead of going up a little bit each day, it goes down a big amount.

The larger the spread between what’s happening, and what should be happening, the larger the chance of a buyout.

Another disconnect is sentiment.

The more ridiculous the price action, and the more ridiculous the reasons behind the price action, the more likely your company is to be bought out.

Wall Street is a treacherous place. Or, as Obi-Wan Kenobi put it, “You will never find a more wretched hive of scum and villainy.”

<< Previous
Bullboard Posts
Next >>